IDEXX Laboratories Inc $ 276.07 -0.73 (-0.26%)
Volume:
53,408
Avg Vol (1m):
377,914
Market Cap $:
23.76 Bil
Enterprise Value $:
24.68 Bil
P/E (TTM):
59.61
P/B:
141.16
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Peter Lynch Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $276.07 | ||
Manual of Stocks™ Web
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.11 | ||
| Equity-to-Asset | 0.1 | ||
| Debt-to-Equity | 6.05 | ||
| Debt-to-EBITDA | 1.69 | ||
| Interest Coverage | 15.78 | ||
| Piotroski F-Score | 8 | ||
| Altman Z-Score | 12.75 | ||
| Beneish M-Score | -2.35 | ||
| WACC vs ROIC | |||
Profitability | 10/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 23.14 | ||
| Net Margin % | 17.78 | ||
| ROE % | 1193.91 | ||
| ROA % | 25.43 | ||
| ROC (Joel Greenblatt) % | 81.4 | ||
| 3-Year Revenue Growth Rate | 13.5 | ||
| 3-Year EBITDA Growth Rate | 18 | ||
| 3-Year EPS without NRI Growth Rate | 27.6 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 59.61 | ||
| Forward PE Ratio | 49.75 | ||
| PE Ratio without NRI | 59.61 | ||
| Price-to-Owner-Earnings | 77.65 | ||
| PB Ratio | 141.16 | ||
| PS Ratio | 10.57 | ||
| Price-to-Free-Cash-Flow | 88.49 | ||
| Price-to-Operating-Cash-Flow | 58.02 | ||
| EV-to-EBIT | 46.52 | ||
| EV-to-EBITDA | 40.13 | ||
| EV-to-Revenue | 10.77 | ||
| PEG Ratio | 3.32 | ||
| Shiller PE Ratio | 114.75 | ||
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.83 | ||
| Days Inventory | 67.15 | ||
| Days Sales Outstanding | 45.59 | ||
| Days Payable | 24.79 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 6.86 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 3 | ||
| Price-to-Median-PS-Value | 2.47 | ||
| Price-to-Peter-Lynch-Fair-Value | 3.18 | ||
| Earnings Yield (Greenblatt) % | 2.15 | ||
| Forward Rate of Return (Yacktman) % | 19.75 |